Most Recent
Biotechs to battle in Federal Court over ‘Access’ trade marks
Intellectual Property February 5, 2020 2:49 pm By Cat Fredenburgh

Two biotech companies that provide molecular diagnostic products used in genetic screening will face off in Federal Court over whether one of the company’s ‘Access’ […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Lawyer wins $750,000 in defamation case over negative Google reviews
Defamation February 7, 2020 10:35 pm By Christine Caulfield

An Adelaide lawyer has been awarded $750,000 in damages after suing a woman who gave him bad reviews on Google that sent 80 per cent […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Judge tosses Vagisil maker’s challenge to European rival’s trade mark
Intellectual Property February 4, 2020 11:43 am By Miklos Bolza

The international company behind the Vagisil feminine hygiene brand has lost its bid to stop a European competitor from registering Vagisan as a trade mark […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Country Care, prosecutors to battle it out over cartel charges ahead of trial
Competition & Consumer Protection November 6, 2019 8:31 pm By Miklos Bolza

Mobility equipment provider Country Care Group will fight for the dismissal of three charges brought by federal prosecutors in the country’s first criminal cartel case […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Biosimilar drug makers settle IP spat over arthritis drug Humira
Intellectual Property January 21, 2020 2:21 pm By Christine Caulfield

German drug company Fresenius Kadi has resolved a patent case brought by Korean drug company Samsung Bioepis over a biosimilar of top selling arthritis drug […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Pelvic mesh cases remind judge of the days when ‘mobile phones resembled house bricks’
Class Actions December 18, 2019 10:52 pm By Miklos Bolza

A Federal Court judge has frowned on a bid to transfer 12 individual cases over allegedly defective pelvic mesh to various state and territory courts, […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

FWC dismisses case after Facebook pics show ‘agoraphobic’ beautician sunning it up
Employment January 28, 2020 8:30 pm By Miklos Bolza

The Fair Work Commission has dismissed a general protections dispute brought by an “agoraphobic” beautician after social media posts revealed an active social life including […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Bupa takes regulator to court as it fights ACCC allegations it overcharged, misled residents
Competition & Consumer Protection January 21, 2020 10:04 pm By Christine Caulfield

Bupa has launched court action to block a directive by the Aged Care Quality and Safety Commission as the aged care provider battles a separate […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Court approves settlement in NSW ambulance privacy class action
Class Actions December 10, 2019 4:12 pm By Miklos Bolza

The NSW Supreme Court has approved a settlement in Australia’s first privacy class action, which was brought against the NSW government over a data breach […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Pfizer takes Sandoz to court for info on Enbrel biosimilar
Intellectual Property November 12, 2019 5:51 pm By Cat Fredenburgh

Pfizer, maker of the blockbuster rheumatoid arthritis biologic Enbrel, has taken generic drug maker Sandoz to court for information on its Enbrel biosimilar, after winning […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.